Mutant GTP cyclohydrolase I in autosomal dominant dystonia and recessive hyperphenylalaninemia

Neurology

Volumn 52, Issue 1, 1999, Pages 182-184

  Hirano, Makito ^a   Ueno, Satoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOPA; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; MUTANT PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSTONIA; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERPHENYLALANINEMIA; PRIORITY JOURNAL; RECESSIVE INHERITANCE;

EID: 0032957414     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.1.182     Document Type: Article

References (10)

1. Davis MD, Ribeiro P, Tipper J, Kaufman S. "7-Tetrahydrobiopterin," a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases. Proc Natl Acad Sci USA 1992;89:10109-10113.
2. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8: 236-242.
3. Hirano M, Tamaru Y, Ito H, Matsumoto S, Imai T, Ueno S. Mutant GTP cyclohydrolase I mRNA levels contribute to doparesponsive dystonia onset. Ann Neurol 1996;40:796-798.
4. Hirano M, Imaiso Y, Ueno S. Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Biochem Biophys Res Commun 1997;234:316-319.
5. Tamaru Y, Hirano M, Ito H, et al. Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene. J Neurol Neurosurg Psychiatry 1998;64:469-473.
6. Bezin L, Nygaard TG, Neville JD, Shen H, Levine RA. Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia. Neurology 1998;50: 1021-1027.
7. Blau N, Ichinose H, Nagatsu T, Heizmann CW, Zacchello F, Burlina AB. A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J Pediatr 1995;126:401-405.
8. Fukushima K, Richter WE Jr, Shiota T. Partial purification of 6-(D-eryiAro-1′,2′,3′-trihydroxypropyl)-7,8-dihydropterin triphosphate synthetase from chicken liver. J Biol Chem 1977;252: 5750-5755.
9. Miyamura N, Araki E, Matsuda K, et al. A carboxy-terminal truncation of human α-galactosidase A in a heterozygous female with Fabry disease and modification of the enzymatic activity by the carboxy-terminal domain. Increased, reduced, or absent enzyme activity depending on number of amino acid residues deleted. J Clin Invest 1996;98:1809-1817.
10. Furukawa Y, Kish SJ, Bebin EM, et al. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol 1998;44:10-16.